Cargando…

The involvement of hyperhomocysteinemia in the development of characterized depressive disorder in children and adolescents

INTRODUCTION: Elevated blood levels of homocysteine have been associated with several psychiatric and neurodegenerative disorders such as schizophrenic disorders, Alzheimer’s disease, Parkinson’s disease and depression. The hypothesis is that genetic and environmental factors elevate homocysteine le...

Descripción completa

Detalles Bibliográficos
Autores principales: Elmaataoui, Z., BELHADGA, H., KISRA, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596173/
http://dx.doi.org/10.1192/j.eurpsy.2023.633
_version_ 1785125041545936896
author Elmaataoui, Z.
BELHADGA, H.
KISRA, H.
author_facet Elmaataoui, Z.
BELHADGA, H.
KISRA, H.
author_sort Elmaataoui, Z.
collection PubMed
description INTRODUCTION: Elevated blood levels of homocysteine have been associated with several psychiatric and neurodegenerative disorders such as schizophrenic disorders, Alzheimer’s disease, Parkinson’s disease and depression. The hypothesis is that genetic and environmental factors elevate homocysteine levels, which causes vascular diseases of the brain, and/or changes in neurotransmitters, which cause various mental disorders. OBJECTIVES: The objective of our work is to discuss the association between hyperhomocysteinemia and the characterized depressive disorder METHODS: we conducted our study through the discussion of a clinical vignette RESULTS: We report here a case of hyperhomocysteinemia with vitamin B 12 deficiency in a 16-year-old female patient who presented with a characterized depressive disorder. She was initially treated with a selective serotonin inhibitor combined with parenteral injections of vitamin B12. The patient’s clinical condition improved after the first week. The discussion will attempt to clarify the role of vitamin therapy in the improvement of the patient’s depressive symptoms and its relationship with hyperhomocysteinemia. We report here a case of hyperhomocysteinemia with vitamin B 12 deficiency in a 16-year-old female patient who presented with a characterized depressive disorder.She was initially treated with a selective serotonin inhibitor combined with parenteral injections of vitamin B12. The patient’s clinical condition improved after the first week. The discussion will attempt to clarify the role of vitamin therapy in the improvement of the patient’s depressive symptoms and its relationship with hyperhomocysteinemia. CONCLUSIONS: Statistical data, physiological and genetic aspects seem to point to the involvement of hyperhomocysteinemia in the development of characterized depressive disorder. However, the results remain variable, even contradictory, and several confounding factors must be considered in these studies: ethnic, geographical, cultural (in terms of diet) and age factors are all elements that seem to intervene and that do not always make it possible to know whether hyperhomocysteinemia is a direct cause of depression or the consequence of mechanisms linked to folate and B12 deficiencies. DISCLOSURE OF INTEREST: None Declared
format Online
Article
Text
id pubmed-10596173
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-105961732023-10-25 The involvement of hyperhomocysteinemia in the development of characterized depressive disorder in children and adolescents Elmaataoui, Z. BELHADGA, H. KISRA, H. Eur Psychiatry Abstract INTRODUCTION: Elevated blood levels of homocysteine have been associated with several psychiatric and neurodegenerative disorders such as schizophrenic disorders, Alzheimer’s disease, Parkinson’s disease and depression. The hypothesis is that genetic and environmental factors elevate homocysteine levels, which causes vascular diseases of the brain, and/or changes in neurotransmitters, which cause various mental disorders. OBJECTIVES: The objective of our work is to discuss the association between hyperhomocysteinemia and the characterized depressive disorder METHODS: we conducted our study through the discussion of a clinical vignette RESULTS: We report here a case of hyperhomocysteinemia with vitamin B 12 deficiency in a 16-year-old female patient who presented with a characterized depressive disorder. She was initially treated with a selective serotonin inhibitor combined with parenteral injections of vitamin B12. The patient’s clinical condition improved after the first week. The discussion will attempt to clarify the role of vitamin therapy in the improvement of the patient’s depressive symptoms and its relationship with hyperhomocysteinemia. We report here a case of hyperhomocysteinemia with vitamin B 12 deficiency in a 16-year-old female patient who presented with a characterized depressive disorder.She was initially treated with a selective serotonin inhibitor combined with parenteral injections of vitamin B12. The patient’s clinical condition improved after the first week. The discussion will attempt to clarify the role of vitamin therapy in the improvement of the patient’s depressive symptoms and its relationship with hyperhomocysteinemia. CONCLUSIONS: Statistical data, physiological and genetic aspects seem to point to the involvement of hyperhomocysteinemia in the development of characterized depressive disorder. However, the results remain variable, even contradictory, and several confounding factors must be considered in these studies: ethnic, geographical, cultural (in terms of diet) and age factors are all elements that seem to intervene and that do not always make it possible to know whether hyperhomocysteinemia is a direct cause of depression or the consequence of mechanisms linked to folate and B12 deficiencies. DISCLOSURE OF INTEREST: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10596173/ http://dx.doi.org/10.1192/j.eurpsy.2023.633 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Elmaataoui, Z.
BELHADGA, H.
KISRA, H.
The involvement of hyperhomocysteinemia in the development of characterized depressive disorder in children and adolescents
title The involvement of hyperhomocysteinemia in the development of characterized depressive disorder in children and adolescents
title_full The involvement of hyperhomocysteinemia in the development of characterized depressive disorder in children and adolescents
title_fullStr The involvement of hyperhomocysteinemia in the development of characterized depressive disorder in children and adolescents
title_full_unstemmed The involvement of hyperhomocysteinemia in the development of characterized depressive disorder in children and adolescents
title_short The involvement of hyperhomocysteinemia in the development of characterized depressive disorder in children and adolescents
title_sort involvement of hyperhomocysteinemia in the development of characterized depressive disorder in children and adolescents
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596173/
http://dx.doi.org/10.1192/j.eurpsy.2023.633
work_keys_str_mv AT elmaataouiz theinvolvementofhyperhomocysteinemiainthedevelopmentofcharacterizeddepressivedisorderinchildrenandadolescents
AT belhadgah theinvolvementofhyperhomocysteinemiainthedevelopmentofcharacterizeddepressivedisorderinchildrenandadolescents
AT kisrah theinvolvementofhyperhomocysteinemiainthedevelopmentofcharacterizeddepressivedisorderinchildrenandadolescents
AT elmaataouiz involvementofhyperhomocysteinemiainthedevelopmentofcharacterizeddepressivedisorderinchildrenandadolescents
AT belhadgah involvementofhyperhomocysteinemiainthedevelopmentofcharacterizeddepressivedisorderinchildrenandadolescents
AT kisrah involvementofhyperhomocysteinemiainthedevelopmentofcharacterizeddepressivedisorderinchildrenandadolescents